Two Munich startups, Nanotype and Xerion Pharmaceuticals, have joined forces to develop a protein chip for studying neural stem cell behavior and differentiation, Nanotype said Dec. 13.
Developing the chip will take two to three years, with funding for the first year provided by a grant from the German Ministry of Research.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
